| Serial Number | 88937246 |
| Word Mark | EMPOUIK |
| Filing Date | Thursday, May 28, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 26, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 30, 2021 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 17, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Tuesday, December 27, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, December 26, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, May 13, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 11, 2022 | SOU EXTENSION 2 GRANTED |
| Wednesday, May 11, 2022 | SOU EXTENSION 2 FILED |
| Wednesday, May 11, 2022 | TEAS EXTENSION RECEIVED |
| Friday, November 19, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 17, 2021 | SOU EXTENSION 1 GRANTED |
| Wednesday, November 17, 2021 | SOU EXTENSION 1 FILED |
| Wednesday, November 17, 2021 | TEAS EXTENSION RECEIVED |
| Tuesday, May 25, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 30, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 30, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 10, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, February 19, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, February 18, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 17, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 17, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, August 30, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, August 30, 2020 | NON-FINAL ACTION E-MAILED |
| Sunday, August 30, 2020 | NON-FINAL ACTION WRITTEN |
| Sunday, August 30, 2020 | ASSIGNED TO EXAMINER |
| Wednesday, June 17, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, June 1, 2020 | NEW APPLICATION ENTERED IN TRAM |